Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Other Non-Current Liabilities: 2021-2025

Historic Other Non-Current Liabilities for Molecular Partners Ag (MOLN) over the last 4 years, with Sep 2025 value amounting to $2,654.

  • Molecular Partners Ag's Other Non-Current Liabilities fell 3.47% to $2,654 in Q3 2025 from the same period last year, while for Sep 2025 it was $2,654, marking a year-over-year decrease of 3.47%. This contributed to the annual value of $2,113 for FY2024, which is 42.91% up from last year.
  • As of Q3 2025, Molecular Partners Ag's Other Non-Current Liabilities stood at $2,654, which was up 11.47% from $2,381 recorded in Q2 2025.
  • Over the past 5 years, Molecular Partners Ag's Other Non-Current Liabilities peaked at $8,013 during Q4 2021, and registered a low of $1,497 during Q4 2023.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $2,665 (2025), whereas its average is $2,675.
  • Per our database at Business Quant, Molecular Partners Ag's Other Non-Current Liabilities slumped by 72.24% in 2022 and then surged by 41.74% in 2024.
  • Quarterly analysis of 5 years shows Molecular Partners Ag's Other Non-Current Liabilities stood at $8,013 in 2021, then tumbled by 72.24% to $2,224 in 2022, then tumbled by 32.70% to $1,497 in 2023, then surged by 41.74% to $2,122 in 2024, then decreased by 3.47% to $2,654 in 2025.
  • Its Other Non-Current Liabilities was $2,654 in Q3 2025, compared to $2,381 in Q2 2025 and $2,665 in Q1 2025.